Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol

Chronic obstructive pulmonary disease (COPD) causes trouble breathing. People with COPD may use inhalers with 2 (dual therapy) or 3 medications (triple therapy [TT]). This study found that people using TT were less likely to have an episode of COPD symptom worsening compared with those using dual th...

Full description

Saved in:
Bibliographic Details
Published in:Journal of managed care & specialty pharmacy 2023-07, Vol.29 (7), p.791-806
Main Authors: Sethi, Sanjay, Palli, Swetha R, Bengtson, Lindsay G S, Buysman, Erin K, Clark, Brendan, Sargent, Andrew, Shaikh, Asif, Ferguson, Gary T
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chronic obstructive pulmonary disease (COPD) causes trouble breathing. People with COPD may use inhalers with 2 (dual therapy) or 3 medications (triple therapy [TT]). This study found that people using TT were less likely to have an episode of COPD symptom worsening compared with those using dual therapy. However, this benefit was not seen in people using these as their first treatment. People using TT also had higher treatment costs.
ISSN:2376-0540
2376-1032
DOI:10.18553/jmcp.2023.22373